Oral small-molecule GLP-1
GSBR-1290
Stage Phase 2
Indications Obesity, Type 2 Diabetes
Last updated:Jul 15, 2026Source:ClinicalTrials.gov + sponsor pipeline pagesVerified:Manually reviewedData provider:PeptidePlanet Research
Mechanism
Oral non-peptide GLP-1 receptor agonist competing with peptide injectables.
Educational summary. Not medical advice. See sponsor materials and peer-reviewed literature for full pharmacology.
Companies developing it
1Related trials
0No trials linked to this peptide in our dataset.
Current research
Data unavailableCurated peer-reviewed research links launch once our editorial pipeline is verified.
Safety summary
Data unavailableSafety summaries require a verified regulatory data source and clinical review. Consult the FDA label and sponsor prescribing information for approved products.